[Federal Register Volume 83, Number 240 (Friday, December 14, 2018)]
[Notices]
[Pages 64364-64365]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27131]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Arizona Department 
of Corrections

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration or the proposed authorization to 
import on or before January 14, 2019. Such persons may also file a 
written request for a hearing on the application for registration and 
for authorization to import on or before January 14, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: Pursuant to 21 U.S.C. 958(i), the Attorney 
General shall, prior to issuing a regulation under 21 U.S.C. 
952(a)(2)(B) authorizing the importation of a controlled substance in 
schedule I or II, provide manufacturers holding registrations for the 
bulk manufacture of the substance an opportunity for a hearing. 
Additionally, pursuant to 21 CFR 1301.34(a), the Administrator of the 
Drug Enforcement Administration (DEA) shall, upon the filing of an 
application for registration to import a controlled substance in 
schedule I or II under 21 U.S.C. 952(a)(2)(B), provide notice and the 
opportunity to request a hearing to manufacturers holding registrations 
for the bulk manufacture of the substance and to applicants for such 
registrations.
    The Attorney General has delegated his authority under the 
Controlled Substances Act,\1\ including the provisions codified at 21 
U.S.C. 952 and

[[Page 64365]]

958, to the DEA Administrator, 28 CFR 0.100(b). Authority to exercise 
all necessary functions with respect to the promulgation and 
implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been delegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
---------------------------------------------------------------------------

    \1\ The provisions of federal law relating to the import and 
export of controlled substances--those found in 21 U.S.C. 951 
through 971--are more precisely referred to as the Controlled 
Substances Import and Export Act. However, federal courts and DEA 
often use the term ``Controlled Substances Act'' to refer 
collectively to all provisions from 21 U.S.C. 801 through 971 and, 
for ease of exposition, this document will do likewise.
---------------------------------------------------------------------------

    Therefore, in accordance with 21 U.S.C. 958(i) and 21 CFR 
1301.34(a), this is notice that on June 11, 2018, Arizona Department of 
Corrections, 1305 E Butte Avenue, ASPC-Florence, Florence, Arizona 
85132-9221, re-applied to be registered as an importer of Pentobarbital 
(2270), a basic class of the controlled substance listed in schedule 
II.
    The facility intends to import the above-listed controlled 
substance for legitimate use. This particular controlled substance is 
not available for the intended legitimate use within the current 
domestic supply of the United States.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture this basic class of controlled 
substance may file comments or objections to the issuance of the 
proposed registration or to the authorization of this importation, and 
may, at the same time, file a written request for a hearing. Any such 
comments, objections, or hearing requests should be addressed as 
described above.

    Dated: December 4, 2018.
 John J. Martin,
Assistant Administrator.
[FR Doc. 2018-27131 Filed 12-13-18; 8:45 am]
BILLING CODE 4410-09-P